TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Income from Continuing Operations (2020 - 2023)

Updated

TFA Therapeutics (RAJAF) reported Income from Continuing Operations of -$154,822 for FY2025, compared with -$226,258 in FY2024.

Analysis

TFA Therapeutics (RAJAF) Income from Continuing Operations (2020 - 2023) Analysis & Trends

Dating back to FY2020, TFA Therapeutics' Income from Continuing Operations record includes 6 years.

  • Five-year annual Income from Continuing Operations spans a low of -$415,111 in FY2022 and a high of $169,285 in FY2023.
  • According to Business Quant data, Income from Continuing Operations came in at -$226,258 in FY2024, $169,285 in FY2023, -$415,111 in FY2022 and -$119,380 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Procter & Gamble 383.82 Bn 335.63 Bn 11.60 Bn 4.76 Bn
2 Colgate Palmolive 77.64 Bn 72.70 Bn 3.30 Bn 719.00 Mn
3 Estee Lauder Companies 39.02 Bn 27.10 Bn 2.74 Bn -116.00 Mn
4 Kenvue 38.19 Bn 33.81 Bn 2.30 Bn 456.00 Mn
5 Kimberly Clark 37.36 Bn 34.68 Bn 1.60 Bn 410.00 Mn
6 Church & Dwight 25.82 Bn 24.35 Bn 693.90 Mn 202.80 Mn
7 Clorox 10.72 Bn 9.16 Bn 804.00 Mn 167.00 Mn
8 e.l.f. Beauty 6.78 Bn 5.75 Bn 398.84 Mn 66.60 Mn
9 Reynolds Consumer Products 4.98 Bn 4.64 Bn 245.00 Mn 138.00 Mn
10 TFA Therapeutics 1.02 Bn 1.02 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 61,900.00
Dec 31, 2022 -36,891.00
Dec 31, 2020 -11,534.00
API Access

TFA Therapeutics Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=RAJAF&period=max&api_key=YOUR_API_KEY